# A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

> **NCT01316133** · PHASE4 · TERMINATED · sponsor: **Astellas Pharma Korea, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT01316133
- **Lead sponsor:** Astellas Pharma Korea, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04-19
- **Primary completion:** 2016-04-08
- **Final completion:** 2016-04-08
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Study terminated due to poor patient recruitment.
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316133, "A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01316133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*